Aurinia Pharmaceuticals Inc (AUPH)

4.865 -0.16 (-3.28%) USD  |  NASDAQ  |  Apr 25, 16:00
4.865 0.00 (0.00%) After-Hours: 20:00
More

Aurinia Pharmaceuticals PE Ratio

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2011. Upgrade now.
Date Value
May 15, 2012 380.69
May 07, 2012 489.04
March 31, 2012
March 26, 2012
March 19, 2012
February 27, 2012
January 06, 2012
Date Value
December 31, 2011
November 02, 2011 417.73
October 28, 2011 499.78
October 27, 2011 499.78
October 25, 2011 488.39
October 20, 2011 478.62

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

Lexaria Bioscience Corp --
Acasti Pharma Inc --
Edesa Biotech Inc --
Xenon Pharmaceuticals Inc --
ESSA Pharma Inc --

PE Ratio Related Metrics

PS Ratio 3.963
Price to Book Value 1.861
Price 4.865
Earnings Yield -10.89%
Market Cap 703.57M